Th17 immune response in IBD

A new pathogenic mechanism

Flavio Caprioli, Francesco Pallone, Giovanni Monteleone

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Although traditionally associated with exaggerated Th1 or Th2 cell response, the gut inflammation occurring in patients with IBD is also characterized by production of cytokines made by a distinct lineage of T helper cells, termed Th17 cells. The discovery that this new inflammatory T-cell subset drives immune-mediated pathology and that the antigen-presenting cell-derived IL-23 is necessary for amplifying Th17 cell-associated inflammation has contributed to elucidate new pathways of intestinal tissue damage as well as to open new avenues for development of therapeutic strategies in IBD. In this review, we discuss the available data regarding the involvement of Th17 cells and their interplay with other mucosal cell types in the modulation of intestinal tissue inflammation.

Original languageEnglish
Pages (from-to)291-295
Number of pages5
JournalJournal of Crohn's & colitis
Volume2
Issue number4
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Th17 Cells
Inflammation
Interleukin-23
Th2 Cells
Th1 Cells
T-Lymphocyte Subsets
Antigen-Presenting Cells
Helper-Inducer T-Lymphocytes
Pathology
Cytokines
Therapeutics

Keywords

  • Crohn's disease
  • IL-17
  • IL-23
  • Inflammatory bowel disease (IBD)
  • Th17
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Th17 immune response in IBD : A new pathogenic mechanism. / Caprioli, Flavio; Pallone, Francesco; Monteleone, Giovanni.

In: Journal of Crohn's & colitis, Vol. 2, No. 4, 12.2008, p. 291-295.

Research output: Contribution to journalArticle

Caprioli, Flavio ; Pallone, Francesco ; Monteleone, Giovanni. / Th17 immune response in IBD : A new pathogenic mechanism. In: Journal of Crohn's & colitis. 2008 ; Vol. 2, No. 4. pp. 291-295.
@article{cb21364bef7841c9aa0a4f450eb1173c,
title = "Th17 immune response in IBD: A new pathogenic mechanism",
abstract = "Although traditionally associated with exaggerated Th1 or Th2 cell response, the gut inflammation occurring in patients with IBD is also characterized by production of cytokines made by a distinct lineage of T helper cells, termed Th17 cells. The discovery that this new inflammatory T-cell subset drives immune-mediated pathology and that the antigen-presenting cell-derived IL-23 is necessary for amplifying Th17 cell-associated inflammation has contributed to elucidate new pathways of intestinal tissue damage as well as to open new avenues for development of therapeutic strategies in IBD. In this review, we discuss the available data regarding the involvement of Th17 cells and their interplay with other mucosal cell types in the modulation of intestinal tissue inflammation.",
keywords = "Crohn's disease, IL-17, IL-23, Inflammatory bowel disease (IBD), Th17, Ulcerative colitis",
author = "Flavio Caprioli and Francesco Pallone and Giovanni Monteleone",
year = "2008",
month = "12",
doi = "10.1016/j.crohns.2008.05.004",
language = "English",
volume = "2",
pages = "291--295",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Th17 immune response in IBD

T2 - A new pathogenic mechanism

AU - Caprioli, Flavio

AU - Pallone, Francesco

AU - Monteleone, Giovanni

PY - 2008/12

Y1 - 2008/12

N2 - Although traditionally associated with exaggerated Th1 or Th2 cell response, the gut inflammation occurring in patients with IBD is also characterized by production of cytokines made by a distinct lineage of T helper cells, termed Th17 cells. The discovery that this new inflammatory T-cell subset drives immune-mediated pathology and that the antigen-presenting cell-derived IL-23 is necessary for amplifying Th17 cell-associated inflammation has contributed to elucidate new pathways of intestinal tissue damage as well as to open new avenues for development of therapeutic strategies in IBD. In this review, we discuss the available data regarding the involvement of Th17 cells and their interplay with other mucosal cell types in the modulation of intestinal tissue inflammation.

AB - Although traditionally associated with exaggerated Th1 or Th2 cell response, the gut inflammation occurring in patients with IBD is also characterized by production of cytokines made by a distinct lineage of T helper cells, termed Th17 cells. The discovery that this new inflammatory T-cell subset drives immune-mediated pathology and that the antigen-presenting cell-derived IL-23 is necessary for amplifying Th17 cell-associated inflammation has contributed to elucidate new pathways of intestinal tissue damage as well as to open new avenues for development of therapeutic strategies in IBD. In this review, we discuss the available data regarding the involvement of Th17 cells and their interplay with other mucosal cell types in the modulation of intestinal tissue inflammation.

KW - Crohn's disease

KW - IL-17

KW - IL-23

KW - Inflammatory bowel disease (IBD)

KW - Th17

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=56449102268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449102268&partnerID=8YFLogxK

U2 - 10.1016/j.crohns.2008.05.004

DO - 10.1016/j.crohns.2008.05.004

M3 - Article

VL - 2

SP - 291

EP - 295

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 4

ER -